SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Mark Bartlett who wrote (3267)2/3/2000 5:22:00 PM
From: Claude Cormier  Read Replies (1) | Respond to of 14101
 
Hello Mark,

I have this question for you or anyone else on the thread who might have the answer.

Lets forget WF10 for now...

Has there been any forecasts made so far on how much sales DMX could have from Pennsaid alone in the coming years ?

After all, DMX has a market cap of $300M and no sales. I know the money will come.. but how much ?



To: Mark Bartlett who wrote (3267)2/3/2000 5:36:00 PM
From: Claude Cormier  Read Replies (2) | Respond to of 14101
 
Mark,

I also read that they now have U.K. approval to sell Pennsaid there and need to conclude on only a few details. They will then move to other Euro nations.

What about the US.. What is the status of licensing there? Has there been any kind of approval from the FDA?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News